Is MTVA or NAMSW more undervalued in 2026?

CirclFi compares MetaVia Inc. (MTVA) and NewAmsterdam Pharma Company N.V (NAMSW) using 13 institutional-grade valuation models. MTVA has a Quality of Company score of 3.7/10 while NAMSW scores 2.2/10.

Which is a better buy — MTVA or NAMSW?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MTVA and NAMSW valuations compare?

MTVA at $2.84 and NAMSW at $25.00 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MTVA vs NAMSW Valuation Comparison 2026 — Intrinsic Value Analysis

MTVA

Pharmaceutical Preparations

MetaVia Inc.

Quality

3.7

out of 10

Value Trap

LOW

Price

$2.84

Last close

Models

9/13

Active

NAMSW

Pharmaceutical Preparations

NewAmsterdam Pharma Company N.V

Quality

2.2

out of 10

Value Trap

—

Price

$25.00

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	MTVA Fair Value	MTVA Upside	NAMSW Fair Value	NAMSW Upside
Bayesian DCF	Intrinsic	$1.70	-40.1%	—	—
Earnings Power Value	Intrinsic	$0.83	-42.4%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.02	-98.7%	$3.60	-83.1%
Dynamic NAV	Asset-Based	$4.03	+41.9%	$6.79	-68.0%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MTVA vs NAMSW — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MTVA vs NAMSW — Which Stock Is More Undervalued?

MTVA scores higher with a 3.7/10 quality rating vs NAMSW's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing MetaVia Inc. (MTVA) and NewAmsterdam Pharma Company N.V (NAMSW) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MTVA currently trades at $2.84 with a QOC of 3.7/10, while NAMSW trades at $25.00 with a QOC of 2.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).